Skip to main content

Advertisement

SpringerLink
Log in

ADAM-17 associated with CD44 cleavage and metastasis in oral squamous cell carcinoma

  • Original Article
  • Published:
Virchows Archiv Aims and scope Submit manuscript

Abstract

ADAM-17 (a disintegrin and metalloproteinase 17) is a membrane-anchored protein, which can cleave the ectodomain in a variety of transmembrane proteins. In the in vitro experiments with tumor cells, ADAM-17 is reported to cleave CD44, an adhesion molecule that interacts with hyaluronic acid, to promote tumor cell migration. In the present study, we examined ADAM-17 expression and CD44 cleavage in specimens from 50 patients diagnosed to have oral squamous cell carcinoma (SCC). Each specimen was divided into two pieces, one was studied by immunohistochemistry and the other was subjected to a Western blot. By coordinating the results of both analyses, ADAM-17 expression was evaluated to be high in 23 cases (46%). When CD44 cleavage was also studied by immunohistochemical staining as well as with Western blotting, CD44 cleavage was judged to be positive in 29 cases (58%). When the ADAM-17 expression level was compared with the CD44 cleavage state, most of the cases expressing high levels of ADAM-17 (87%) showed positive CD44 cleavage. The level of ADAM-17 expression was significantly correlated to the nodal metastasis and local recurrence in oral SCC. Our findings suggest that ADAM-17 is involved in CD44 cleavage and contributes to tumor progression in oral SCC.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Black RA, Rauch CT, Kozlosky CJ, Peschon JJ, Slack JL, Wolfson MF, Castner BJ, Stocking KL, Reddy P, Srinivasan S, Nelson N, Boiani N, Schooley KA, Gerhart M, Davis R, Fitzner JN, Johnson RS, Paxton RJ, March CJ, Cerretti DP (1997) A metalloproteinase disintegrin that releases tumour-necrosis factor-α from cells. Nature 385:729–733

    Article  PubMed  CAS  Google Scholar 

  2. Blanchot-Jossic F, Jarry A, Masson D, Bach-Ngohou K, Paineau J, Denis MG, Laboisse CL, Mosnier JF (2005) Up-regulated expression of ADAM-17 in human colon carcinoma: co-expression with EGFR in neoplastic and endothelial cells. J Pathol 207:156–163

    Article  PubMed  CAS  Google Scholar 

  3. Borrell-Pages M, Rojo F, Albanell J, Baselga J, Arribas J (2003) TACE is required for the activation of the EGFR by TGF-α in tumors. EMBO J 22:1114–1124

    Article  PubMed  CAS  Google Scholar 

  4. De Marzo AM, Bradshaw C, Sauvageot J, Epstein JI, Miller GJ (1998) CD44 and CD44v6 downregulation in clinical prostatic carcinoma: relation to Gleason grade and cytoarchitecture. J Hered 34:162–168

    Google Scholar 

  5. Fabre-Lafay S, Garrido-Urbani S, Reymond N, Goncalves A, Dubreuil P, Lopez M (2005) Nectin-4, a new serological breast cancer marker, is a substrate for tumor necrosis factor-a-converting enzyme (TACE)/ADAM-17. J Biol Chem 280:19543–19550

    Article  PubMed  CAS  Google Scholar 

  6. Fonseca I, Pereira T, Rosa-Santos J, Soares J (2001) Expression of CD44 isoforms in squamous cell carcinoma of the border of the tongue: a correlation with histological grade, pattern of stromal invasion, and cell differentiation. J Surg Oncol 76:115–120

    Article  PubMed  CAS  Google Scholar 

  7. Gao AC, Lou W, Dong JT, Isaacs JT (1997) CD44 is a metastasis suppressor gene for prostatic cancer located on human chromosome 11p13. Cancer Res 57:846–849

    PubMed  CAS  Google Scholar 

  8. Guo YJ, Liu G, Wang X, Jin D, Wu M, Ma J, Sy MS (1994) Potential use of soluble CD44 in serum as indicator of tumor burden and metastasis in patients with gastric or colon cancer. Cancer Res 54:422–426

    PubMed  CAS  Google Scholar 

  9. Kajita M, Itoh Y, Chiba T, Mori H, Okada A, Kinoh H, Seiki M (2001) Membrane-type 1 matrix metalloproteinase cleaves CD44 and promotes cell migration. J Cell Biol 153:893–904

    Article  PubMed  CAS  Google Scholar 

  10. Karan D, Lin FC, Bryan M, Ringel J, Moniaux N, Lin MF, Batra SK (2003) Expression of ADAMs (a disintegrin and metalloproteases) and TIMP-3 (tissue inhibitor of metalloproteinase-3) in human prostatic adenocarcinoma. Int J Oncol 23:1365–1371

    PubMed  CAS  Google Scholar 

  11. Moss ML, Jin SLC, Milla ME, Burkhart W, Carter HL, Chen WJ, Clay WC, Didsbury JR, Hassler D, Hoffman CR, Kost TA, Lambert MH, Leesnitzer MA, McCauley P, McGeehan G, Mitchell J, Moyer M, Pahel G, Rocque W, Overton LK, Schoenen F, Seaton T, Su JL, Warner J, Willard D, Becherer JD (1997) Cloning of a disintegrin metalloproteinase that processes precursor tumour-necrosis factor-α. Nature 385:733–736

    Article  PubMed  CAS  Google Scholar 

  12. Nagano O, Murakami D, Hartmann D, de Strooper B, Saftig P, Iwatsubo T, Nakajima M, Shinohara M, Saya H (2004) Cell-matrix interaction via CD44 is independently regulated by different metalloproteinases activated in response to extracellular Ca2+ influx and PKC activation. J Cell Biol 165:893–902

    Article  PubMed  CAS  Google Scholar 

  13. Nakamura H, Suenaga N, Taniwaki K, Matsuki H, Yonezawa K, Fujii M, Okada Y, Seiki M (2004) Constitutive and induced CD44 shedding by ADAM-like proteases and membrane-type 1 matrix metalloproteinase. Cancer Res 64:876–882

    Article  PubMed  CAS  Google Scholar 

  14. Okamoto I, Kawano Y, Tsuiki H, Sasaki J, Nakao M, Matsumoto M, Suga M, Ando M, Nakajima M, Saya H (1999) CD44 cleavage induced by membrane-associated metalloprotease plays a critical role in tumor cell migration. Oncogene 18:1435–1446

    Article  PubMed  CAS  Google Scholar 

  15. Okamoto I, Tsuiki H, Kenyon LC, Godwin AK, Emlet DR, Holgado-Madruga M, Lanham IS, Joynes CJ, Vo KT, Guha A, Matsumoto M, Ushio Y, Saya H, Wong AJ (2002) Proteolytic cleavage of the CD44 adhesion molecule in multiple human tumors. Am J Pathol 160:441–447

    PubMed  CAS  Google Scholar 

  16. Ponta H, Sherman L, Herrlich PA (2003) CD44: from adhesion molecules to signalling regulators. Nature Rev Mol Cell Biol 4:33–45

    Article  CAS  Google Scholar 

  17. Sato S, Miyauchi M, Takekoshi T, Zhao M, Kudo Y, Ogawa I, Kitagawa S, Fujita M, Takata T (2000) Reduced expression of CD44 variant 9 is related to lymph node metastasis and poor survival in squamous cell carcinoma of tongue. Oral Oncol 36:545–549

    Article  PubMed  CAS  Google Scholar 

  18. Seals DF, Courtneidge SA (2003) The ADAMs family of metalloproteinases: multidomain proteins with multiple functions. Genes Dev 17:7–30

    Article  PubMed  CAS  Google Scholar 

  19. Sheen-Chen SM, Chen WJ, Eng HL, Sheen CC, Chou FF, Cheng YF (1999) Evaluation of the prognostic value of serum soluble CD44 in patients with breast cancer. Cancer Invest 17:581–585

    Article  PubMed  CAS  Google Scholar 

  20. Shtivelman E, Bishop J (1991) Expression of CD44 is repressed in neuroblastoma cells. Mol Cell Biol 11:5446–5453

    PubMed  CAS  Google Scholar 

  21. Tanaka Y, Miyamoto S, Suzuki SO, Oki E, Yagi H, Sonoda K, Yamazaki A, Mizushima H, Maehara Y, Mekada E, Nakano H (2005) Clinical significance of heparin-binding epidermal growth factor-like growth factor and a disintegrin and metalloprotease 17 expression in human ovarian cancer. Clin Cancer Res 11:4783–4792

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgment

This work was supported by a grant from the Ministry of Education, Science, and Culture of Japan (to M. Shinohara).

Author information

Authors and Affiliations

  1. Department of Oral and Maxillofacial Surgery, Graduate School of Medical Sciences, Kumamoto University, 1-1-1 Honjo, Kumamoto, 860-8556, Japan

    Yasuo Takamune, Tetsuro Ikebe, Osamu Nagano, Hideki Nakayama, Kazutoshi Ota, Takehisa Obayashi & Masanori Shinohara

  2. Department of Tumor Genetics and Biology, Graduate School of Medical Sciences, Kumamoto University, 1-1-1 Honjo, Kumamoto, 860-8556, Japan

    Osamu Nagano & Hideyuki Saya

  3. Department of Oral and Maxillofacial Surgery, Fukuoka Dental College, 2-15-1 Tamura, Sawara-ku, Fukuoka, 814-0193, Japan

    Tetsuro Ikebe

Authors
  1. Yasuo Takamune
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Tetsuro Ikebe
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Osamu Nagano
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Hideki Nakayama
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Kazutoshi Ota
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Takehisa Obayashi
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Hideyuki Saya
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Masanori Shinohara
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Tetsuro Ikebe.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Takamune, Y., Ikebe, T., Nagano, O. et al. ADAM-17 associated with CD44 cleavage and metastasis in oral squamous cell carcinoma. Virchows Arch 450, 169–177 (2007). https://doi.org/10.1007/s00428-006-0350-y

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00428-006-0350-y

Keywords

Search

Navigation